Related Experiment Video

Updated: Feb 8, 2026

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes
16:26

Regulatory T cells: Therapeutic Potential for Treating Transplant Rejection and Type I Diabetes

Published on: August 20, 2007

6.2K

Analysis of the regulation pathways via microarray and miRNA studies: human embryonic stem cells to treat diabetes

Geeta Shroff1, Rhea Shroff2, Rakesh Gupta3

  • 1Nutech Mediworld H-8, Green Park Extension, New Delhi-110016, India.

American Journal of Stem Cells
|June 26, 2018
PubMed

Insights

Human embryonic stem cells (hESCs) show promise for treating type 2 diabetes. Microarray and miRNA analyses reveal hESCs up-regulate insulin secretion pathways, suggesting potential for pancreatic beta cell regeneration.

Area of Science:

  • Stem cell biology
  • Endocrinology
  • Genomics

Background:

  • Diabetes mellitus, including Type 1 and Type 2, presents significant health challenges with severe long-term complications.
  • Conventional treatments for diabetes have limitations and are associated with adverse outcomes.
  • Previous research indicated the therapeutic potential of human embryonic stem cells (hESCs) in patients with type 2 diabetes.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying the effectiveness of hESCs in managing type 2 diabetes.
  • To investigate the impact of hESCs on diabetic pathways using transcriptomic and microRNA analyses.

Main Methods:

  • Culturing of three samples of hESCs.
  • Microarray analysis to assess diabetic pathways.
  • Gene Ontology (GO) and DAVID database for miRNA gene target analysis.
  • Reactome and Panther databases for pathway determination.

Main Results:

  • Microarray and miRNA analyses identified significant up-regulation of insulin secretion, binding, and positive regulation pathways.
  • Pathways involved in the negative regulation of insulin were significantly down-regulated.
  • Gene expression changes were confirmed with significant p-values.

Conclusions:

  • hESCs demonstrate a molecular profile conducive to improving insulin regulation.
  • The observed up-regulation of insulin secretion pathways suggests that hESCs possess the capability to regenerate pancreatic beta cells upon transplantation.
  • These findings provide a mechanistic basis for the therapeutic efficacy of hESCs in type 2 diabetes.
Keywords:
Diabeteshuman embryonic stem cellsmicroarray technology

More Related Videos

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers04:09

Prospective, Randomized, and Controlled Study of a Human Umbilical Cord Mesenchymal Stem Cell Injection for Treating Diabetic Foot Ulcers

Published on: March 3, 2023

3.8K
Video Bioinformatics Analysis of Human Embryonic Stem Cell Colony Growth13:11

Video Bioinformatics Analysis of Human Embryonic Stem Cell Colony Growth

Published on: May 20, 2010

13.1K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
5.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
5.4K
Embryonic Stem Cells00:58

Embryonic Stem Cells

Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
32.5K
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
5.1K
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.1K
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
28.1K